Hu J - Search Results

1

Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE₂/β-catenin signalling pathway.

Che D, Zhang S, Jing Z, Shang L, Jin S, Liu F, Shen J, Li Y, Hu J, Meng Q, Yu Y. Che D, et al. Among authors: hu j. Mol Immunol. 2017 Oct;90:197-210. doi: 10.1016/j.molimm.2017.06.018. Epub 2017 Aug 21. Mol Immunol. 2017. PMID: 28837884

2

Downregulation of MDM2 expression by RNAi inhibits LoVo human colorectal adenocarcinoma cells growth and the treatment of LoVo cells with mdm2siRNA3 enhances the sensitivity to cisplatin.

Yu Y, Sun P, Sun LC, Liu GY, Chen GH, Shang LH, Wu HB, Hu J, Li Y, Mao YL, Sui GJ, Sun XW. Yu Y, et al. Among authors: hu j. Biochem Biophys Res Commun. 2006 Jan 6;339(1):71-8. doi: 10.1016/j.bbrc.2005.10.181. Epub 2005 Nov 8. Biochem Biophys Res Commun. 2006. PMID: 16297858

3

RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.

Feng Y, Hu J, Ma J, Feng K, Zhang X, Yang S, Wang W, Zhang J, Zhang Y. Feng Y, et al. Among authors: hu j. Eur J Cancer. 2011 Oct;47(15):2353-63. doi: 10.1016/j.ejca.2011.05.006. Epub 2011 Jun 15. Eur J Cancer. 2011. PMID: 21680174

4

Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis.

Wei HB, Lu XS, Shang LH, Xu G, Hu J, Che DH, Liu F, Wu Y, Zhang GM, Yu Y. Wei HB, et al. Among authors: hu j. Arch Med Res. 2011 Jul;42(5):412-20. doi: 10.1016/j.arcmed.2011.07.008. Epub 2011 Aug 7. Arch Med Res. 2011. PMID: 21827803

5

A meta-analytic review of ERCC1/MDR1 polymorphism and chemosensitivity to platinum in patients with advanced non-small cell lung cancer.

Wei HB, Hu J, Shang LH, Zhang YY, Lu FF, Wei M, Yu Y. Wei HB, et al. Among authors: hu j. Chin Med J (Engl). 2012 Aug;125(16):2902-7. Chin Med J (Engl). 2012. PMID: 22932088 Review.

6

Predictive factors analysis for malignant peritoneal mesothelioma.

Jin S, Cao S, Cao J, Shen J, Hu J, Che D, Zhang J, Yu Y. Jin S, et al. Among authors: hu j. J Gastrointest Surg. 2015 Feb;19(2):319-26. doi: 10.1007/s11605-014-2664-4. Epub 2014 Oct 9. J Gastrointest Surg. 2015. PMID: 25297446

7

Advances in malignant peritoneal mesothelioma.

Cao S, Jin S, Cao J, Shen J, Hu J, Che D, Pan B, Zhang J, He X, Ding D, Gu F, Yu Y. Cao S, et al. Among authors: hu j. Int J Colorectal Dis. 2015 Jan;30(1):1-10. doi: 10.1007/s00384-014-2029-1. Epub 2014 Oct 21. Int J Colorectal Dis. 2015. PMID: 25331029 Review.

8

Overexpression of Sphk2 is associated with gefitinib resistance in non-small cell lung cancer.

Liu W, Ning J, Li C, Hu J, Meng Q, Lu H, Cai L. Liu W, et al. Among authors: hu j. Tumour Biol. 2016 May;37(5):6331-6. doi: 10.1007/s13277-015-4480-1. Epub 2015 Dec 1. Tumour Biol. 2016. PMID: 26628299

9

TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.

Xing Y, Meng Q, Chen X, Zhao Y, Liu W, Hu J, Xue F, Wang X, Cai L. Xing Y, et al. Among authors: hu j. Oncotarget. 2016 May 24;7(21):30479-91. doi: 10.18632/oncotarget.8586. Oncotarget. 2016. PMID: 27058415 Free PMC article.

10

Mammalian Eps15 homology domain 1 promotes metastasis in non-small cell lung cancer by inducing epithelial-mesenchymal transition.

Meng Q, Xing Y, Ren T, Lu H, Xi Y, Jiang Z, Hu J, Li C, Sun L, Sun D, Cai L. Meng Q, et al. Among authors: hu j. Oncotarget. 2017 Apr 4;8(14):22433-22442. doi: 10.18632/oncotarget.11220. Oncotarget. 2017. PMID: 27531895 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,231 results

Search Page

Filters